QC
ARVN icon

Quantedge Capital’s Arvinas ARVN Stock Holding History

Quantedge Capital’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,600
Closed -$165K – 51
2026
Q1 		$165K Buy
+15,600
New +$193K 0.09% 50

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantedge Capital's ARVN Position: Q2 2026 in Review

Quantedge Capital sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 15,600 shares — an estimated $165K sold.

Quantedge Capital first reported a position in ARVN in Q1 2026 and held it in 1 quarter. The position peaked at $165K in Q1 2026. 202 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Quantedge Capital reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
  • Quantedge Capital sold 15,600 Arvinas shares in Q2 2026, an estimated $165K.
  • Quantedge Capital first reported a position in Arvinas in Q1 2026 and held it in 1 quarter.
  • Quantedge Capital's Arvinas position peaked at $165K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Quantedge Capital's 13F filing for Q2 2026, filed 6 Aug 2026.